Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.32 million versus the consensus estimate of $2.04 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.